
    
      Prospective, multi-center 1:1 randomized Study.

      Patients will be stratified according to a stent-avoiding (study arm) or stent-preferred
      (control arm)

      In total 120 patient will be enrolled in this study, each strata will include 60 patients.

      All enrolled patients will be followed up for 24 month to asses the incidence of restenosis
      by duplex ultrasound and major adverse events.

      Follow-up visits occur at 6, 12 and 24 month intervals as well as telephone visit after 1,36,
      48 and 60 month.
    
  